Description
This assay uses the Luminex® 200™ platform.
Consider this assay for a comprehensive evaluation of 12 key cytokines associated with Th17 immune responses. The Mouse Cytokine Th17 12-Plex Discovery Assay® Array (MDTH17-12) includes critical biomarkers such as IL-17A, IL-21, IL-22, IL-23, and IL-33.
This panel is particularly valuable for studying Th17-mediated immune responses and their role in inflammatory and autoimmune diseases. For example, IL-17A and IL-23 are central to the pathogenesis of conditions like psoriasis and rheumatoid arthritis, while IL-22 and IL-31 are involved in skin inflammation and itch.
By analyzing these cytokines simultaneously, researchers can gain deeper insights into the complex network of Th17-related signaling and its impact on disease mechanisms, making this assay an essential tool for investigating Th17-driven pathologies.
For a more comprehensive immune profile, consider running the Mouse Cytokine/Chemokine 32-Plex Discovery Assay® Array (MD32) in addition to this assay. The MD32 is our most popular mouse array, providing an extensive cytokine and chemokine profile by measuring 32 biomarkers simultaneously from a small sample volume. This array includes key markers such as IL-6, TNFα, and VEGF-A, offering a broad view of immune responses and inflammatory pathways. Combining these assays will give you a more detailed and holistic understanding of the immune landscape in your mouse models.
Discover the power of precision with our assay, expertly designed for the Luminex® 200™ platform. This cutting-edge technology enables the simultaneous detection of multiple biomarkers from a minimal single sample, delivering comprehensive insights with unmatched efficiency. Streamline your research and unlock a new level of detail with our advanced multiplex assay solution.
Click here for information on shipping biological samples for Discovery Assays